Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Pancreatic Neoplasms 3Carcinoma, Renal Cell 3Triple Negative Breast Neoplasms 2Lung Neoplasms 2Kidney Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urothelial Bladder Carcinoma 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Recurrence 1Ovarian Neoplasms 1Metastatic Urothelial Cancer 1Melanoma 1Lung Diseases 1Glioblastoma 1Esophageal Neoplasms 1Erythrocytosis, Familial, 4 1Cholangiocarcinoma 1Advanced Solid Tumors 1Advanced Non-Small Cell Lung Cancer 1

Interventions

Injections 8pembrolizumab 4Pemetrexed 4Carboplatin 4Oxaliplatin 3Leucovorin 3Fluorouracil 3trifluridine tipiracil drug combination 2sotorasib 2fludarabine 2Paclitaxel 2Drug Therapy 2Docetaxel 2Bevacizumab 2zimberelimab 1trametinib 1toripalimab 1tislelizumab 1sacituzumab govitecan 1netrin-1 inhibitor NP137 1cemiplimab 1WW Domain-Containing Oxidoreductase 1SYS6006 COVID-19 vaccine 1Panitumumab 1Irinotecan 1Immune Checkpoint Inhibitors 1Etoposide 1Cyclophosphamide 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × zimberelimab × 90 days × Clear all
NCT06532565 2026-04-21

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

Gilead Sciences

Phase 1 Recruiting
154 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡